Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma
Clinical trial NCT03486509 · UNKNOWN
Trial details
- NCT number
- NCT03486509
- Sponsor
- Fujian Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-01
- Primary completion
- 2020-03-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.